Blood clots often form when lipid-rich plaques on the inner surface of arteries rupture and platelets aggregate at the site of injury. LMU cardiologists have now compared the effects of two new platelet aggregation inhibitors.
The German care system for patients with acute and unspecific chest pain is unique in Europe. The closely knit and countrywide network of accredited Chest Pain Units (CPUs) ensures fast and targeted diagnosis of acute cardiac events. The German CPUs may soon serve as a blueprint for other European countries. The German Cardiac Society (DGK) has already accredited the first institutions – others…
A research paper published in the New England Journal of Medicine (NEJM) today confirms earlier findings that a procedure called endovascular therapy (ET) for ischemic stroke is the best treatment option for many patients by reducing the incidents of disability. This is the fourth research paper published this year that confirms the efficacy of the treatment.
Seeing a substantially increasing importance of the cardiac MRI procedure, cardiologists have developed a specialist cardiac MRI training programme for their colleagues.
In the year of Shimadzu’s 140th anniversary, new systems continue the company’s tradition in diagnostic imaging providing innovative technologies and industry firsts.
Imec, Medtronic, Ghent University and their project partners today announced the launch of the CARDIS project. Together they will develop and validate an early-stage cardio vascular disease detection platform using integrated silicon photonics.
Cardiovascular disease develops in a slow and subclinical manner over decades, only to manifest suddenly and unexpectedly. Prevention is crucial, both before and after clinical appearance, Report: Dr Eduardo de la Sota
Cardiomyopathy is a disease with many faces, a 'chameleon', according to Professor Jeanette Schulz-Menger. MRI benefits and potential should be communicated better and to a wider clinical audience. Report: Axel Viola
In the year of its 40th anniversary, Schiller proudly presents an algorithm which immediately and accurately localises coronary occlusions and provides early detection of STEMI. This algorithm is now integrated in the sophisticated touch ECG devices, the Cardovit MS line.
CardioSecur, a personalised mobile 12-lead ECG system with four electrodes for iPhone and iPad, enables patients to monitor their symptoms and transmit the data to their physicians in less than a minute.
In uncomplicated stable angina cases no evidence suggests that angioplasty reduces heart attacks or death risks, Mark Nicholls reports
The ‘Fire of Life’ developed by Schiller is an intuitive visual presentation of frequency-domain heart rate variability (HRV) that makes the assessment of 24-hour results fast and simple.
By recognition and early intervention against the most significant risk factors, many heart diseases can be prevented.
The heart is a structure in three dimensions and today we see it in three dimensions,’ Jose Luis Zamorano Gomez MD declared with satisfaction.
Researchers at Johns Hopkins Bayview Medical Center used two relatively simple tactics to significantly reduce the number of unnecessary blood tests to assess symptoms of heart attack and chest pain and to achieve a large decrease in patient charges.
Synchronised Cardiac Assist i-cor, which the company reports to be the first system that links mechanical circulatory support to the heartbeat.
It was the quiet before the storm. At the end of March, during the American College of Cardiology (ACC) meeting in Washington, the future of renal denervation was about to be decided with the presentation of the Medtronic-funded Simplicity HTN-3 clinical trial.
Biotronik, a leading manufacturer of cardiovascular medical technology, announced CE approval for its new Eluna pacemaker series. The new generation of pacemakers includes single and dual-chamber as well as cardiac resynchronization (CRT-P) devices.
It is the quiet before the storm. At the end of March, the future of renal denevation will be decided with the presentation of the Simplicity HTN-3 clinical trial at the American College of Cardiology meeting in Washington.
Fully implantable mechanical hearts bring hope to 121,000 heart failure patients who will never receive a heart transplant
Edwards Lifesciences Corporation, the global leader in the science of heart valves and hemodynamic monitoring, announced that it has received CE Mark in Europe and is initiating the launch of its most advanced transcatheter aortic valve, the Edwards SAPIEN 3 valve.
Despite the availability of cardioversion, ablation and medications to treat AF, outcomes are often poor because it is unclear which patients will benefit most. A new classification of atrial fibrillation (AF) by electrocardiogram (ECG) is set to be developed by European experts to aid personalised management of this devastating condition.
The Plaque-CharM project funded by the German Federal Ministry of Education and Research is to develop novel sensor technology that can characterise arterial tissue in the smallest space – the tip of a catheter.
Since minimally invasive surgery (MIS) entered cardiac surgery in the mid-1990s it became unthinkable not to use this medical specialty. However, MIS procedures do not always result in the best outcome for patients.
Prevention Suite’s four combined imaging technologies enables practical pre-clinical assessment of cardiovascular disease risk .